These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2699998)

  • 1. Role of dietary lipids and renal eicosanoids on the progression of renal disease.
    Klahr S; Harris K
    Kidney Int Suppl; 1989 Nov; 27():S27-31. PubMed ID: 2699998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.
    Shohat J; Boner G
    Isr J Med Sci; 1993 Apr; 29(4):228-39. PubMed ID: 8491578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosanoids: role in experimental renal disease.
    Klahr S; Purkerson ML
    Adv Exp Med Biol; 1989; 259():249-74. PubMed ID: 2696355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat.
    Gröne HJ; Walli A; Gröne E; Niedmann P; Thiery J; Seidel D; Helmchen U
    Lab Invest; 1989 Mar; 60(3):433-46. PubMed ID: 2927082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary soy protein reduces early renal disease progression and alters prostanoid production in obese fa/fa Zucker rats.
    Hwang SY; Taylor CG; Zahradka P; Bankovic-Calic N; Ogborn MR; Aukema HM
    J Nutr Biochem; 2008 Apr; 19(4):255-62. PubMed ID: 17656081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and renal disease.
    Trevisan R; Dodesini AR; Lepore G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S145-7. PubMed ID: 16565240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids in progression of renal disease.
    Oda H; Keane WF
    Kidney Int Suppl; 1997 Nov; 62():S36-8. PubMed ID: 9350676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia and progressive renal disease.
    Keane WF; Mulcahy WS; Kasiske BL; Kim Y; O'Donnell MP
    Kidney Int Suppl; 1991 Apr; 31():S41-8. PubMed ID: 2046270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet.
    Kume S; Uzu T; Araki S; Sugimoto T; Isshiki K; Chin-Kanasaki M; Sakaguchi M; Kubota N; Terauchi Y; Kadowaki T; Haneda M; Kashiwagi A; Koya D
    J Am Soc Nephrol; 2007 Oct; 18(10):2715-23. PubMed ID: 17855643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease.
    Peng CY; Sankaran D; Ogborn MR; Aukema HM
    Exp Biol Med (Maywood); 2009 Jul; 234(7):737-43. PubMed ID: 19429858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet.
    Zhou Y; Lin S; Chang HH; Du J; Dong Z; Dorrance AM; Brands MW; Wang MH
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):530-7. PubMed ID: 15831364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic implications of lipid-lowering agents in the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP; Schmitz PG
    Am J Med; 1989 Nov; 87(5N):21N-24N. PubMed ID: 2486540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary fat and mammary cancer. II. Modulation of serum and tumor lipid composition and tumor prostaglandins by different dietary fats: association with tumor incidence patterns.
    Cohen LA; Thompson DO; Choi K; Karmali RA; Rose DP
    J Natl Cancer Inst; 1986 Jul; 77(1):43-51. PubMed ID: 3459925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of lipoproteins on the development and progression of renal disease.
    Dalrymple LS; Kaysen GA
    Am J Nephrol; 2008; 28(5):723-31. PubMed ID: 18434711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosanoids and renal vascular function in diseases.
    Imig JD
    Clin Sci (Lond); 2006 Jul; 111(1):21-34. PubMed ID: 16764555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease.
    Kasiske BL; O'Donnell MP; Schmitz PG; Keane WF
    Adv Nephrol Necker Hosp; 1991; 20():109-25. PubMed ID: 2063707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.